Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade

Current Biology

Volumn 8, Issue 18, 1998, Pages 1001-1008

  Juo, Peter ^a   Kuo, Calvin J ^a,b   Yuan, Junying ^a   Blenis, John ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032505127     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(07)00420-4     Document Type: Article

References (57)

1. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.
2. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, et al.: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989, 245:301-305.
3. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (Anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989, 169:1747-1756.
4. Abbas AK: Die and let live: eliminating dangerous lymphocytes. Cell 1996, 84:655-657.
5. Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei C-F, et al.: Protection against Fas/APO-1- and Tumor Necrosis Factor-mediated cell death by a novel protein, Sentrin. J Immunol 1996, 157:4277-4281.
6. Sato T, Irie S, Kitada S, Reed JC: FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995, 268:411-415.
7. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B: RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995, 81:513-523.
8. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
9. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995, 270:7795-7798.
10. Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997, 89:1067-1076.
11. Zhang J, Cado D, Chen A, Kabra NH, Winoto A: Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392:296-300.
12. Yeh W-C, Pompa JL, McCurrach ME, Shu H-B, Elia AJ, Shahinian A, et al.: FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279:1954-1958.
13. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P: The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 1998, 8:297-303.
14. Yuan J: Transducing signals of life and death. Curr Opin Cell Biol 1997, 9:247-251.
15. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997, 326:1-16.
16. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced death. Cell 1996, 85:803-815.
17. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et al.: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
18. Muzio M, Salvesen GS, Dixit VM: FLICE induced apoptosis in a cell-free system. J Biol Chem 1997, 272:2952-2956.
19. Srinivasula SM, Ahmad M, Fernandez-Alnemri T, Litwack G, Alnemri ES: Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996, 93:14486-14491.
20. Yang X, Chang HY, Baltimore D: Autoproteolytic activation of procaspases by oligomerization. Mol Cell 1998, 1:319-325.
21. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, et al.: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997, 16:2794-2804.
22. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM: An induced proximity model for caspase-8 activation. J Biol Chem 1998, 273:2926-2930.
23. Memon SA, Hou J-Z, Moreno MB, Zacharchuk CM: Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins. J Immunol 1998, 160:2046-2049.
24. Martin DA, Siegel RM, Zheng L, Lenardo MJ: Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHαD death signal. J Biol Chem 1998, 273:4345-4349.
25. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, et al.: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996, 93:7464-7469.
26. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alenmri T, et al.: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997, 57:615-619.
27. Duan H, Dixit VM: RAIDD is an new 'death' adaptor molecule. Nature 1997, 385:86-89.
28. Vincenz C, Dixit VM: Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem 1997, 272:6578-6583.
29. Hsu H, Huang J, Shu H-B, Baichwal V, Goeddel DV: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996, 4:387-396.
30. Pellegrini S, John J, Shearer M, Kerr IM, Stark GR: Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol Cell Biol 1989, 9:4605-4612.
31. John J, McKendry R, Pellegrini S, Flavell D, Kerr IM, Stark GR: Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol Cell Biol 1991, 11:4189-4195.
32. Scaffidi C, Medema JP, Krammer PH, Peter ME: FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 1997, 272:26953-26958.
33. Su X, Zhou T, Wang Z, Yang P, Jope RS, Mountz JD: Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 1995, 2:353-362.
34. Li H, Bergeron L, Cryns V, Pasternack MS, Zhu H, Shi L, et al.: Activation of caspase-2 in apoptosis. J Biol Chem 1997, 272:21010-21017.
35. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, et al.: Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J 1995, 14:6148-6156.
36. Cahill MA, Peter ME, Kischkel FC, Chinnaiyan AM, Dixit VM, Krammer PH, et al.: CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 1996, 13:2087-2096.
37. Huang S, Jiang Y, Li Z, Nishida E, Mathias P, Lin S, et al.: Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 1997, 6:739-749.
38. Lenczowski JM, Dominguez L, Eder AM, King LB, Zacharchuk CM, Ashwell JD: Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 1997, 17:170-181.
39. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, et al.: Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 1997, 17:24-35.
40. Hsu H, Shu H-B, Pan M-G, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996, 84:299-308.
41. Stancovski I, Baltimore D: NF-κB activation: the IκB kinase revealed? Cell 1997, 91:299-302.
42. Ting AT, Pimentel-Muinos FX, Seed B: RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J 1996, 15:6189-6196.
43. Herr I, Wilhelm D, Bohler T, Angel P, Debatin K-M: Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 1997, 16:6200-6208.
44. Kasibhatla S, Brunner T, Echeverri F, Mahboubi A, Green DR: DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol Cell 1998, 1:543-551.
45. Fulda S, Sieverts H, Friesen C, Herr I, Debatin K-M: The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997, 57:3823-3829.
46. Friesen C, Herr I, Krammer PH, Debatin K-M: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 1996, 2:574-577.
47. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, et al.: Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 1998, 140:171-182.
48. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM: Ultraviolet radiation-induced apoptosis is mediated by activation of CD95 (Fas/APO-1). J Biol Chem 1997, 272:25783-25786.
49. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, et al.: Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 1997, 90:935-943.
50. Gamen S, Anel A, Lasierra P, Alava MA, Martinez-Lorenzo MJ, Pineiro A, et al.: Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett 1997, 417:360-364.
51. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, et al.: Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 1997, 57:3331-3334.
52. Chen R-H, Sarnecki C, Blenis J: Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 1992, 12:915-927.
53. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, et al.: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993, 329:1982-1987.
54. rsk) in somatic cells: phosphorylation and activation during initiation of cell proliferation. Mol Cell Biol 1990, 10:3204-3215.
55. Gupta S, Cambell D, Derijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995, 267:389-393.
56. Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 1988, 67:31-40.
57. Itoh N, Tsujimotot Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunology 1993, 151:621-627.